Johnson & Johnson inks $700M deal to resolve talc consumer protection claims from 42 states
Johnson & Johnson inks $700M deal to resolve talc consumer protection claims from 42 states kdunleavy Tue, 01/23/2024 - 14:33
Johnson & Johnson inks $700M deal to resolve talc consumer protection claims from 42 states kdunleavy Tue, 01/23/2024 - 14:33
Ahead of key Stelara patent cliff, J&J's pharma business churns out growth fkansteiner Tue, 01/23/2024 - 11:32
Genmab loses appeal in Darzalex royalties arbitration case against Johnson & Johnson kdunleavy Tue, 01/23/2024 - 10:24
J&J, Legend's Carvykti bid for earlier multiple myeloma use will face FDA adcomm aliu Tue, 01/23/2024 - 10:14
FDA wants classwide boxed warning on all commercial CAR-T therapies amid secondary cancer safety probe aliu Mon, 01/22/2024 - 23:42
Lundbeck CEO eyes deals to bolster pipeline, complement growth drivers ahead of patent losses zbecker Mon, 01/22/2024 - 17:26